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M. Cejna1* and W. Hofmann2
Departments of 1Radiology, and 2Vascular Surgery, Academic Teaching Hospital,
LKH Feldkirch, Carinagasse 47, A-6800 Feldkirch, AustriaThis prospective randomized controlled trial by Vahl
et al. demonstrated that magnetic resonance angiogra-
phy (MRA) is as effective as digital subtraction angi-
ography (DSA) in pretherapeutic imaging of patients
suffering from symptomatic peripheral arterial ob-
structive disease (PAOD). Effective pretherapeutic im-
aging (demonstration and categorization of in-flow
and out-flow vessels according to TASC categories1)
is a prerequisite for effective management of these
patients. From a clinicians point of view there are dif-
ferent demands for pretherapeutic imaging of patients
suffering from either claudication or critical limb is-
chemia (CLI).
65% of the 394 included limbs were symptomatic,
41% suffering from claudication, 21% from CLI, thus
representing a mixed population. In order to define
specific imaging requirements subgroups consisting
only of claudicants or CLI patients would have made
more relevant populations and would have allowed
more specific conclusions. This study only demon-
strated advantages of non-invasive imaging without
answering the obvious question: which test to order
for which patient.
In a real world scenario there are different modali-
ties for non-invasive imaging. Currently duplex
sonography and magnetic resonance angiographyDOI of original article: 10.1016/j.ejvs.2007.12.002.
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for one modality still pending.2,3 Computed tomogra-
phy angiography (CTA) has demonstrated, in some
publications, advantages over MRA.4,5 Unlike CTA
and duplex sonography, imaging quality in MRA
and DSA studies is not hampered by severe calcifica-
tions often present in the old, diabetic or CTA patients
with renal impairment.
Recently the obvious advantage of MRA e
gadolinium use instead of iodinated contrast in pa-
tients with renal impairment - has been restricted by
occurence of nephrogenic systemic fibrosis (NSF).
This has led to the prevention of gadolinium use in pa-
tients with renal impairment or patients on dialysis
according to FDA recommendations.6 Additionally
dosage has been restricted to single dose instead of
double/or triple dosing of gadolinium routinely em-
ployed by moving table or hybrid MRA (a combina-
tion of stationary MRA for the crural region and
moving bed MRA) as employed in this study. Unfor-
tunately patients suffering from PAOD especially
with CLI are often suffering from renal impairment
and according to recent recommendations shouldn’t
undergo MRA. Consequently prior to an MRA the re-
nal function has to be determined for each patient. In
this study patients with renal impairment were ex-
cluded but primarily only to allow inclusion for DSA.
Pretherapeutic imaging should also be cost-effective
due to the current economic constraints of health
systems. Cost-effective means a MRA approach has
to be as effective (according to outcome measures rele-
vant to the patients such as quality of life (QOL) andr Surgery. Published by Elsevier Ltd. All rights reserved.
523MRA vs DSA: Diagnostic Triallimb salvage) as a DSA approach at compareable total
costs per patient (for evaluation and treatment). In this
study there was no increased rate of complications or
total costs for DSA despite that until now DSA has
beenconsideredmore expensive (due tohospitalization)
and more prone to increased complication rates than
non-invasive cross-sectional imaging. Patients prefer-
ence was the key advantage for MRA.
The studies results doesn’t make vascular medicine
practice easier or more effective to perform, but points
in the direction which way imaging studies should go:
comparison of treatment plans and outcome measure-
ment and total costs. This are the relevant parameters
instead of just correlating stenosis and occlusions
between various imaging modalities.
Limitations of this study are that morphologic
parameters like grade of calcification are not ideally
determined by either MRA or DSA. Grade of calcifica-
tion and length of the lesion are of major impact on
the therapeutic decision in many cases of PAOD in
the pelvis and thigh as well as in the crural region.
Additionally definite recommendations for prethera-
peutic imaging have to be determined for either
claudicants or patients suffering from CLI seperately.References
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